ACE2 and renal cell adenocarcinoma: Of note, the exceptional low rate of ACE2 positivity in chromophobe renal cell cancers (4%) as compared to clear cell (86%) or papillary (94%) renal cell cancers suggests that ACE2 immunohistochemistry may be helpful for renal cell cancer subtype diagnosis.